Page last updated: 2024-08-18

thiophenes and Hyperplasia

thiophenes has been researched along with Hyperplasia in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (66.67)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Alladio, E; Amante, E; Capriotti, AL; Cavaliere, C; Cerrato, A; Laganà, A; Marini, F; Montone, CM; Piovesana, S; Vincenti, M1
Beard, RL; Chandraratna, RA; Escobar, M; Standeven, AM; Yuan, YD1
Furukawa, F; Ikezaki, S; Kasahara, K; Lee, IS; Nishikawa, A; Takahashi, M; Tanakamura, Z1
Fukushima, P; Guedez, L; Mansoor, A; Stetler-Stevenson, M; Stetler-Stevenson, WG; Wang, J; Wolff, L1
Cahill, PA; Hirsch, M; Okada, SS; Redmond, EM; Sitzmann, JV; Wang, YN1
Fabian, CJ; Kimler, BF1
Banai, S; Fishbein, I; Gertz, SD; Golomb, G; Margolin, L; Perez, LS; Reich, R1
Boussiquet-Leroux, C; Duprat, P; Durand-Cavagna, G; Irisarri, E; Molon-Noblot, S; Owen, RA; Peter, CP1
Boussiquet-Leroux, C; Durand-Cavagna, G; Gordon, LR; Owen, RA; Peter, CP1

Reviews

1 review(s) available for thiophenes and Hyperplasia

ArticleYear
Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.
    Annals of the New York Academy of Sciences, 2001, Volume: 952

    Topics: Aneuploidy; Angiogenesis Inhibitors; Anticarcinogenic Agents; Apoptosis; Aromatase Inhibitors; Breast Neoplasms; Carcinoma in Situ; Clinical Trials, Phase II as Topic; Cyclooxygenase Inhibitors; Disease Progression; Eflornithine; Endpoint Determination; Enzyme Inhibitors; Estrogens; Female; Fenretinide; Gonadotropin-Releasing Hormone; Humans; Hyperplasia; Isoflavones; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Phenotype; Piperidines; Polyamines; Precancerous Conditions; Protein-Tyrosine Kinases; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Thiophenes; Uterine Neoplasms

2001

Other Studies

8 other study(ies) available for thiophenes and Hyperplasia

ArticleYear
Comprehensive biomarker profiles and chemometric filtering of urinary metabolomics for effective discrimination of prostate carcinoma from benign hyperplasia.
    Scientific reports, 2022, 03-14, Volume: 12, Issue:1

    Topics: Biomarkers; Biomarkers, Tumor; Carcinoma; Chemometrics; Humans; Hyperplasia; Imidazoles; Male; Metabolomics; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Thiophenes

2022
Mitogenic effect of retinoid X receptor agonists in rat liver.
    Biochemical pharmacology, 1997, Aug-15, Volume: 54, Issue:4

    Topics: Animals; Cell Division; Dose-Response Relationship, Drug; Hepatomegaly; Hyperplasia; Liver; Male; Mitogens; Rats; Rats, Inbred F344; Receptors, Retinoic Acid; Retinoid X Receptors; Thiophenes; Transcription Factors

1997
Chemopreventive activity of oltipraz against induction of glandular stomach carcinogenesis in rats by N-methyl-N'-nitro-N-nitrosoguanidine.
    Carcinogenesis, 1998, Volume: 19, Issue:2

    Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Hyperplasia; Male; Methylnitronitrosoguanidine; Pylorus; Pyrazines; Rats; Rats, Wistar; Stomach Neoplasms; Thiones; Thiophenes

1998
In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.
    The Journal of clinical investigation, 1998, Dec-01, Volume: 102, Issue:11

    Topics: Apoptosis; B-Lymphocytes; bcl-X Protein; Burkitt Lymphoma; Cells, Cultured; Depression, Chemical; Enzyme Inhibitors; Humans; Hyperplasia; Neoplastic Stem Cells; NF-kappa B; Palatine Tonsil; Phenylalanine; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Thiophenes; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tumor Cells, Cultured

1998
Effect of pulse pressure on vascular smooth muscle cell migration: the role of urokinase and matrix metalloproteinase.
    Thrombosis and haemostasis, 1999, Volume: 81, Issue:2

    Topics: Animals; Aprotinin; Blood Pressure; Cell Communication; Cells, Cultured; Coculture Techniques; Collagenases; Endothelium, Vascular; Enzyme Inhibitors; Hemorheology; Humans; Hydroxamic Acids; Hyperplasia; Matrix Metalloproteinase 13; Metalloendopeptidases; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Phenylalanine; Pulse; RNA, Messenger; Stress, Mechanical; Thiophenes; Tunica Intima; Umbilical Veins; Urokinase-Type Plasminogen Activator

1999
Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: augmentative effect of alpha(v)beta(3) receptor blockade.
    Atherosclerosis, 2002, Volume: 163, Issue:2

    Topics: Angioplasty, Balloon; Animals; Arteries; Cell Movement; Constriction, Pathologic; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hydroxamic Acids; Hyperplasia; Male; Matrix Metalloproteinase Inhibitors; Muscle, Smooth, Vascular; Oligopeptides; Phenylalanine; Rats; Receptors, Vitronectin; Thiophenes; Tunica Intima

2002
Rat urinary bladder hyperplasia induced by oral administration of carbonic anhydrase inhibitors.
    Toxicologic pathology, 1992, Volume: 20, Issue:1

    Topics: Acetazolamide; Animals; Carbonic Anhydrase Inhibitors; Epithelium; Hyperplasia; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Rats; Rats, Sprague-Dawley; Sulfonamides; Thiophenes; Urinary Bladder

1992
Urothelial hyperplasia induced by carbonic anhydrase inhibitors (CAIs) in animals and its relationship to urinary Na and pH.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1992, Volume: 18, Issue:1

    Topics: Acetazolamide; Animals; Carbonic Anhydrase Inhibitors; Dogs; Female; Hydrogen-Ion Concentration; Hyperplasia; Macaca mulatta; Male; Mice; Mice, Inbred ICR; Rabbits; Rats; Rats, Inbred Strains; Sodium; Sulfonamides; Thiophenes; Urinary Bladder; Urinary Bladder Diseases

1992